Ken Griffin's position in Regeneron Pharmaceuticals is currently worth $165M. That's 0.14% of their equity portfolio (158th largest holding). The first Regeneron Pharmaceuticals trade was made in Q2 2013. Since then Ken Griffin bought shares 64 more times and sold shares on 53 occasions. The stake costed the investor $155M, netting the investor a gain of 6.1% so far.